as 07-26-2024 4:00pm EST
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Founded: | 1952 | Country: | United States |
Employees: | N/A | City: | PARSIPPANY |
Market Cap: | 82.5B | IPO Year: | 2013 |
Target Price: | $210.86 | AVG Volume (30 days): | 2.0M |
Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 5.19 | EPS Growth: | 17.42 |
52 Week Low/High: | $144.80 - $201.92 | Next Earning Date: | 08-06-2024 |
Revenue: | $8,734,000,000 | Revenue Growth: | 7.91% |
Revenue Growth (this year): | 8.19% | Revenue Growth (next year): | 6.17% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Lagano Roxanne | ZTS | Executive Vice President | Apr 18 '24 | Sell | $151.17 | 923 | $139,529.91 | 14,800 | SEC Form 4 |
Lagano Roxanne | ZTS | Executive Vice President | Mar 18 '24 | Sell | $173.33 | 923 | $159,983.59 | 15,723 | SEC Form 4 |
Reed Willie M | ZTS | Director | Mar 11 '24 | Sell | $182.68 | 1,370 | $250,264.75 | 9,994 | SEC Form 4 |
PECK KRISTIN C | ZTS | Chief Executive Officer | Feb 20 '24 | Sell | $187.20 | 13,000 | $2,433,636.40 | 79,366 | SEC Form 4 |
Lagano Roxanne | ZTS | Executive Vice President | Feb 20 '24 | Sell | $187.30 | 923 | $172,877.90 | 16,646 | SEC Form 4 |
Lagano Roxanne | ZTS | Executive Vice President | Feb 12 '24 | Sell | $197.74 | 363 | $71,779.62 | 20,417 | SEC Form 4 |
Lagano Roxanne | ZTS | Executive Vice President | Feb 12 '24 | Sell | $186.86 | 2,848 | $532,177.28 | 17,569 | SEC Form 4 |
Lagano Roxanne | ZTS | Executive Vice President | Jan 18 '24 | Sell | $191.43 | 923 | $176,689.89 | 17,569 | SEC Form 4 |
Lagano Roxanne | ZTS | Executive Vice President | Dec 18 '23 | Sell | $198.14 | 923 | $182,883.22 | 18,492 | SEC Form 4 |
Lagano Roxanne | ZTS | Executive Vice President | Dec 14 '23 | Sell | $200.00 | 2,500 | $500,000.00 | 19,415 | SEC Form 4 |
ZTS Breaking Stock News: Dive into ZTS Ticker-Specific Updates for Smart Investing
Simply Wall St.
10 hours ago
MT Newswires
a day ago
Simply Wall St.
9 days ago
Simply Wall St.
14 days ago
Zacks
18 days ago
Business Wire
24 days ago
Argus Research
a month ago
Argus Research
a month ago
The information presented on this page, "ZTS Zoetis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.